The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic?
Open accessAbstract
Background and Purpose —The term symptomatic hemorrhage secondary to ischemic stroke implies a clear causal relationship between clinical deterioration and hemorrhagic transformation (HT) regardless of the type of HT. The aim of this study was to assess which type of HT independently affects clinical outcome. Methods —We used the data set of the European Cooperative Acute Stroke Study (ECASS) II for a post hoc analysis. All patients had a control CT scan after 24 to 96 hours or earlier in case of rapid and severe clinical deterioration. HT was categorized according to radiological criteria: hemorrhagic infarction type 1 and type 2 and parenchymal hematoma type 1 and type 2. The clinical course was prospectively documented with the National Institutes of Health Stroke Scale and the modified Rankin Scale. The independent risk of each type of HT was calculated for clinical deterioration at 24 hours and disability and death at 3 months after stroke onset and adjusted for possible confounding factors such as age, severity of stroke syndrome at baseline, and extent of the ischemic lesion on the initial CT. Results —Compared with absence of HT, only parenchymal hematoma type 2 was associated with an increased risk for deterioration at 24 hours after stroke onset (adjusted odds ratio, 18; 95% CI, 6 to 56) and for death at 3 months (adjusted odds ratio, 11; 95% CI, 3.7 to 36). All other types of HT did not independently increase the risk of late deterioration. Conclusions —Only parenchymal hematoma type 2 independently causes clinical deterioration and impairs prognosis. It has a distinct radiological feature: it is a dense homogeneous hematoma >30% of the ischemic lesion volume with significant space-occupying effect.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Hacke, W., Kaste, M., Fieschi, C., von Kummer, R., Davalos, A., Meier, D., Larrue, V., Bluhmki, E., Davis, S., Donnan, G., et al. (1998) · The Lancet · doi:10.1016/s0140-6736(98)08020-9 · Cited by 3,662
Self-citationBarber, P. A., Demchuk, A. M., Zhang, J., & Buchan, A. M. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02237-6 · Cited by 2,668
Hacke, W. (1995) · JAMA · doi:10.1001/jama.1995.03530130023023 · Cited by 2,403
Self-citationFiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777
Self-citationMulticentre Acute Stroke Trial—Italy (MAST-I) Group (1995) · The Lancet · doi:10.1016/s0140-6736(95)92049-8 · Cited by 633
Acute stroke: usefulness of early CT findings before thrombolytic therapy.
von Kummer, R., Allen, K. L., Holle, R., Bozzao, L., Bastianello, S., Manelfe, C., Bluhmki, E., Ringleb, P., Meier, D. H., & Hacke, W. (1997) · Radiology · doi:10.1148/radiology.205.2.9356611 · Cited by 587
Self-citationThrombolytic Therapy with Streptokinase in Acute Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199607183350301 · Cited by 570
Brott, T. G., Haley, E. C., Levy, D. E., Barsan, W., Broderick, J., Sheppard, G. L., Spilker, J., Kongable, G. L., Massey, S., & Reed, R. (1992) · Stroke · doi:10.1161/01.str.23.5.632 · Cited by 545
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Self-citationWolpert, S. M., Brückmann, H., Greenlee, R. G., Wechsler, L. R., Pessin, M. S., & del Zoppo, G. J. (1993) · PubMed Central · Cited by 415
Chiu, D., Krieger, D., Villar-Cordova, C., Kasner, S. E., Morgenstern, L. B., Bratina, P. L., Yatsu, F. M., & Grotta, J. C. (1998) · Stroke · doi:10.1161/01.str.29.1.18 · Cited by 406
Streptokinase for Acute Ischemic Stroke With Relationship to Time of Administration
Donnan, G. A. (1996) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1996.03540120039031 · Cited by 360
Hemorrhagic cerebral infarction--a prospective study.
Hornig, C. R., Dorndorf, W., & Agnoli, A. L. (1986) · Stroke · doi:10.1161/01.str.17.2.179 · Cited by 333
Donnan, G. A. (1996) · JAMA · doi:10.1001/jama.276.12.961 · Cited by 294
Hemorrhagic Transformation and Microvascular Integrity during Focal Cerebral Ischemia/Reperfusion
Hamann, G. F., Okada, Y., & del Zoppo, G. J. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199611000-00036 · Cited by 290
Ischaemic damage of brain microvessels: inherent risks for thrombolytic treatment in stroke
DEL ZOPPO, G. J., VON KUMMER, R., & HAMANN, G. F. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.1 · Cited by 261
Self-citationToni, D., Fiorelli, M., Bastianello, S., Sacchetti, M. L., Sette, G., Argentino, C., Montinaro, E., & Bozzao, L. (1996) · Neurology · doi:10.1212/wnl.46.2.341 · Cited by 205
Self-citationLocal Intra-Arterial Thrombolysis in Acute Ischemic Stroke
Gönner, F., Remonda, L., Mattle, H., Sturzenegger, M., Ozdoba, C., Lövblad, K.-O., Baumgartner, R., Bassetti, C., & Schroth, G. (1998) · Stroke · doi:10.1161/01.str.29.9.1894 · Cited by 188
Tanne, D., Bates, V. E., Verro, P., Kasner, S. E., Binder, J. R., Patel, S. C., Mansbach, H. H., Daley, S., Schultz, L. R., Karanjia, P. N., et al. (1999) · Neurology · doi:10.1212/wnl.53.2.424 · Cited by 178
Percutaneous implantation of autologous vein graft stent for treatment of coronary artery disease
Stefanadis, C., & TOUTOUZAS, P. K. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91066-2 · Cited by 143
Can stroke physicians and neuroradiologists identify signs of early cerebral infarction on CT?
Wardlaw, J. M., Dorman, P. J., Lewis, S. C., & Sandercock, P. A. (1999) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.67.5.651 · Cited by 136
Thrombolytic Agents in the Treatment of Stroke
Pessin, M. S., del Zoppo, G. J., & Estol, C. J. (1990) · Clinical Neuropharmacology · doi:10.1097/00002826-199008000-00001 · Cited by 136
Effectiveness of t-PA in acute ischemic stroke
Buchan, A. M., Barber, P. A., Newcommon, N. J., Karbalai, H., Demchuk, A. M., Hoyte, K., Klein, G., & Feasby, T. E. (2000) · Neurology · doi:10.1212/wnl.54.3.679 · Cited by 134
Bozzao, L., Angeloni, U., Bastianello, S., et al. (1992) · PubMed · Cited by 81
Self-citationMoulin, T., Crépin-Leblond, T., Chopard, J.-L., et al. (2008) · European Neurology · doi:10.1159/000117012 · Cited by 75
Cited by
Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., et al. (2014) · Stroke · doi:10.1161/str.0000000000000024 · Cited by 5,170
Wahlgren, N., Ahmed, N., Dávalos, A., Ford, G. A., Grond, M., Hacke, W., Hennerici, M. G., Kaste, M., Kuelkens, S., Larrue, V., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60149-4 · Cited by 2,379
Self-citationTime to Treatment With Endovascular Thrombectomy and Outcomes From Ischemic Stroke: A Meta-analysis
Saver, J. L., Goyal, M., van der Lugt, A., Menon, B. K., Majoie, C. B. L. M., Dippel, D. W., Campbell, B. C., Nogueira, R. G., Demchuk, A. M., Tomasello, A., et al. (2016) · JAMA · doi:10.1001/jama.2016.13647 · Cited by 2,180
Sacco, R. L., Adams, R., Albers, G., Alberts, M. J., Benavente, O., Furie, K., Goldstein, L. B., Gorelick, P., Halperin, J., Harbaugh, R., et al. (2006) · Stroke · doi:10.1161/01.str.0000199147.30016.74 · Cited by 1,873
Furie, K. L., Kasner, S. E., Adams, R. J., Albers, G. W., Bush, R. L., Fagan, S. C., Halperin, J. L., Johnston, S. C., Katzan, I., Kernan, W. N., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181f7d043 · Cited by 1,492
Metadata
- Authors
- Berger, C., Fiorelli, M., Steiner, T., Schäbitz, W.-R., Bozzao, L., Bluhmki, E., Hacke, W., & von Kummer, R.
- Venue
- Stroke
- Published
- 2001-06
- Volume
- 32
- Issue
- 6
- Pages
- 1330-1335
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2158528601
- Cited by
- 552
- References
- 27
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.